Are drug-eluting stents as useful in patients with diabetes as in nondiabetic patients?

Tayo A. Addo, Issam Moussa

Research output: Contribution to journalArticle

Abstract

Sirolimus-eluting stents have dramatically reduced the risk of instent restenosis following percutaneous coronary intervention. It is unclear whether the magnitude of this benefit is similar between patients with and without diabetes. We analyzed the results of the diabetes subanalysis of the SIRIUS trial to determine whether drug-eluting stents are safe and effective in patients with diabetes and determined that they are effective in reducing angiographic and clinical recurrence to a level similar to non-diabetic patients.

Original languageEnglish (US)
Pages (from-to)18-19+21
JournalCardiology Review
Volume22
Issue number8
StatePublished - Dec 1 2005

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Are drug-eluting stents as useful in patients with diabetes as in nondiabetic patients?'. Together they form a unique fingerprint.

  • Cite this